Novo Integrated Sciences Inc (NVOS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Novo Integrated Sciences Inc (NVOS) has a cash flow conversion efficiency ratio of -0.037x as of November 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-545.92K) by net assets ($14.61 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Novo Integrated Sciences Inc market cap and net worth for the company's overall valuation and market capitalisation.
Novo Integrated Sciences Inc - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how Novo Integrated Sciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Novo Integrated Sciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Novo Integrated Sciences Inc ranked by their cash flow conversion efficiency. Explore NVOS operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Malvern International
LSE:MLVN
|
-0.476x |
|
SEEEN PLC
LSE:SEEN
|
1.594x |
|
Walker Crips Group PLC
LSE:WCW
|
-0.456x |
|
TROUBADOUR RESOURCES INC.
F:2QD0
|
-0.017x |
|
Light Science Technologies Holdings PLC
LSE:LST
|
0.155x |
|
Thor Mining PLC
LSE:THR
|
-0.058x |
|
Vincerx Pharma, Inc. Common Stock
NASDAQ:VINC
|
-2.156x |
|
Jangada Mines Plc
LSE:JAN
|
-0.090x |
Annual Cash Flow Conversion Efficiency for Novo Integrated Sciences Inc (2004–2024)
The table below shows the annual cash flow conversion efficiency of Novo Integrated Sciences Inc from 2004 to 2024. View Novo Integrated Sciences Inc share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-08-31 | $14.61 Million | $-2.24 Million | -0.154x | -67.64% |
| 2023-08-31 | $24.50 Million | $-2.24 Million | -0.092x | +30.86% |
| 2022-08-31 | $44.43 Million | $-5.88 Million | -0.132x | -466.11% |
| 2021-08-31 | $43.80 Million | $-1.02 Million | -0.023x | -56.63% |
| 2020-08-31 | $29.57 Million | $-441.69K | -0.015x | +53.60% |
| 2019-08-31 | $25.54 Million | $-822.27K | -0.032x | +99.40% |
| 2018-08-31 | $172.77K | $-934.50K | -5.409x | -2961.09% |
| 2017-08-31 | $-4.29 Million | $-810.69K | 0.189x | +1419.42% |
| 2016-09-30 | $-7.08 Million | $101.39K | -0.014x | +99.88% |
| 2016-08-31 | $14.75K | $-175.62K | -11.904x | -5235.68% |
| 2015-08-31 | $-625.67K | $-145.03K | 0.232x | -11.88% |
| 2014-08-31 | $-947.87K | $-249.32K | 0.263x | -40.10% |
| 2013-08-31 | $-797.36K | $-350.12K | 0.439x | +126.25% |
| 2012-08-31 | $-2.33 Million | $-451.84K | 0.194x | -81.37% |
| 2011-08-31 | $-1.49 Million | $-1.55 Million | 1.042x | +30.39% |
| 2010-08-31 | $-1.19 Million | $-951.79K | 0.799x | +273.71% |
| 2009-08-31 | $-1.44 Million | $-307.59K | 0.214x | -62.94% |
| 2008-08-31 | $-844.10K | $-486.89K | 0.577x | -62.45% |
| 2007-08-31 | $-296.61K | $-455.65K | 1.536x | +407.69% |
| 2006-08-31 | $-409.22K | $-123.83K | 0.303x | +21.80% |
| 2005-08-31 | $-305.08K | $-75.79K | 0.248x | 0.00% |
| 2004-08-31 | $-305.08K | $-75.79K | 0.248x | -- |
About Novo Integrated Sciences Inc
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, … Read more